BFRI
Price
$0.85
Change
-$0.01 (-1.16%)
Updated
Aug 28 closing price
Capitalization
9.08M
DVAX
Price
$10.27
Change
+$0.01 (+0.10%)
Updated
Aug 28 closing price
Capitalization
1.2B
62 days until earnings call
Interact to see
Advertisement

BFRI vs DVAX

Header iconBFRI vs DVAX Comparison
Open Charts BFRI vs DVAXBanner chart's image
Biofrontera
Price$0.85
Change-$0.01 (-1.16%)
Volume$61.98K
Capitalization9.08M
Dynavax Technologies
Price$10.27
Change+$0.01 (+0.10%)
Volume$1.92M
Capitalization1.2B
BFRI vs DVAX Comparison Chart in %
Loading...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BFRI vs. DVAX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFRI is a Hold and DVAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BFRI: $0.85 vs. DVAX: $10.27)
Brand notoriety: BFRI and DVAX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BFRI: 23% vs. DVAX: 116%
Market capitalization -- BFRI: $9.08M vs. DVAX: $1.2B
BFRI [@Pharmaceuticals: Generic] is valued at $9.08M. DVAX’s [@Pharmaceuticals: Generic] market capitalization is $1.2B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFRI’s FA Score shows that 0 FA rating(s) are green whileDVAX’s FA Score has 0 green FA rating(s).

  • BFRI’s FA Score: 0 green, 5 red.
  • DVAX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BFRI and DVAX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFRI’s TA Score shows that 3 TA indicator(s) are bullish while DVAX’s TA Score has 4 bullish TA indicator(s).

  • BFRI’s TA Score: 3 bullish, 6 bearish.
  • DVAX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than BFRI.

Price Growth

BFRI (@Pharmaceuticals: Generic) experienced а -2.76% price change this week, while DVAX (@Pharmaceuticals: Generic) price change was -6.21% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.16%. For the same industry, the average monthly price growth was +68.07%, and the average quarterly price growth was +81.79%.

Reported Earning Dates

DVAX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.2B) has a higher market cap than BFRI($9.08M). DVAX has higher P/E ratio than BFRI: DVAX (54.60) vs BFRI (0.89). DVAX YTD gains are higher at: -19.577 vs. BFRI (-21.881). BFRI has higher annual earnings (EBITDA): -15.28M vs. DVAX (-34.26M). DVAX has more cash in the bank: 614M vs. BFRI (7.25M). BFRI has less debt than DVAX: BFRI (5M) vs DVAX (285M). DVAX has higher revenues than BFRI: DVAX (316M) vs BFRI (39.2M).
BFRIDVAXBFRI / DVAX
Capitalization9.08M1.2B1%
EBITDA-15.28M-34.26M45%
Gain YTD-21.881-19.577112%
P/E Ratio0.8954.602%
Revenue39.2M316M12%
Total Cash7.25M614M1%
Total Debt5M285M2%
FUNDAMENTALS RATINGS
DVAX: Fundamental Ratings
DVAX
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BFRIDVAX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARV1.710.02
+1.01%
Carver Bancorp
ADV1.84N/A
N/A
Advantage Solutions
SHMD2.63-0.01
-0.38%
SCHMID GROUP N.V.
CWT46.87-0.28
-0.59%
California Water Service
GEN30.21-0.53
-1.72%
Gen Digital

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
-0.99%
ACET - BFRI
25%
Poorly correlated
+0.40%
DVAX - BFRI
23%
Poorly correlated
+0.10%
HCM - BFRI
23%
Poorly correlated
-0.87%
LNTH - BFRI
23%
Poorly correlated
-2.36%
EVO - BFRI
23%
Poorly correlated
+0.57%
More

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+0.10%
ACET - DVAX
39%
Loosely correlated
+0.40%
SNDL - DVAX
35%
Loosely correlated
+6.32%
AMRX - DVAX
33%
Poorly correlated
+2.03%
ESPR - DVAX
32%
Poorly correlated
+1.38%
BCRX - DVAX
32%
Poorly correlated
-0.59%
More